AM

Akash Malviya

Active Director Director DIN 11169937
DIN 11169937 First appointment Jun 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2025
Shareholding value Locked Premium profile

About Akash Malviya

Akash Malviya has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Essensys Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11169937
Primary Designation Director
First Appointment 25 Jun 2025
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Director 25 Jun 2025 2025 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Essensys Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Akash Malviya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash Malviya

Akash Malviya has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Essensys Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Akash Malviya is associated with 1 company as Director.

Akash Malviya has expertise in General Business.

Akash Malviya has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available